EUCRW
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
EUCRW
Delisted
EUCRW was delisted on the 26th of April, 2023.
26 hedge funds and large institutions have $1.09M invested in Eucrates Biomedical Acquisition Corp. Warrant in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
26
Holding in Top 10
–
Calls
$2K
Puts
–
Top Buyers
| 1 | +$15.2K | |
| 2 | +$10.7K | |
| 3 | +$4.24K | |
| 4 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$4.21K |
| 5 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$3.11K |
Top Sellers
| 1 | -$10.4K | |
| 2 | -$6K | |
| 3 | -$5K | |
| 4 |
GCL
Glazer Capital LLC
New York
|
-$1.37K |
| 5 |
Goldman Sachs
New York
|
-$1.03K |